| Biotechnology feed | All feeds
23 /PRNewswire/ - Inimex Pharmaceuticals, Inc.
announced today that it has appointed Michael J.
Abrams, Ph.
D as its President and CEO.
Abrams brings more than 25 years of drug discovery and development experience to Inimex.
He is... PR Newswire via Yahoo!: Nov 23 2009 12:25PM Matching: cardiolite Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
